Single-dose Incremental Intravenous Injection of SY-007 in Healthy Subjects
Status:
Completed
Trial end date:
2020-05-26
Target enrollment:
Participant gender:
Summary
This study is a single-dose incremental, randomized, double-blind, parallel,
placebo-controlled study on safety, tolerance and pharmacokinetics healthy subjects.